GATA2与成人骨髓增生异常性肿瘤及急性髓系白血病中的髓系发育异常和复杂细胞遗传学相关
研究纯化多克隆抗GATA2抗体并制备高特异性单克隆抗体,优化骨髓活检免疫组化,分析健康骨髓、MDS和急性白血病成人中GATA2表达。MDS中GATA2表达与骨髓原始细胞百分比相关,与髓系发育异常和复杂细胞遗传学正相关,为总生存的非独立负向预测因子;AML中GATA2阳性原始细胞百分比与髓系谱系密切相关但与生存无关。
要点
- 健康骨髓中GATA2见于肥大细胞、部分CD34+造血干祖细胞、E-钙黏蛋白阳性红系祖细胞和巨核细胞。
- MDS中GATA2表达与骨髓原始细胞百分比相关,与髓系发育异常和复杂细胞遗传学正相关,为总生存的非独立负向预测因子。
- AML中GATA2阳性原始细胞百分比与髓系谱系密切相关,但与生存无关,且AML中GATA2阳性原始细胞百分比高度可变。
核心结论
- 在MDS中GATA2表达与骨髓原始细胞百分比相关,与髓系发育异常和复杂细胞遗传学正相关,是总生存的非独立负向预测因子。
- 在急性白血病中GATA2阳性原始细胞百分比与髓系谱系密切相关,但AML中该百分比高度可变,且与MDS不同,不预测生存。
研究设计与样本
- 研究纯化多克隆抗GATA2抗体并制备多个高特异性抗GATA2单克隆抗体,优化用于患者骨髓活检样本的免疫组化。
- 分析健康骨髓、MDS和急性白血病成人中GATA2表达。
主要发现
- 健康骨髓中GATA2检测于肥大细胞、部分CD34+造血干祖细胞、E-钙黏蛋白阳性红系祖细胞和巨核细胞。
- MDS中GATA2表达与骨髓原始细胞百分比相关,与髓系发育异常和复杂细胞遗传学正相关,为总生存的非独立负向预测因子。
- 急性白血病中GATA2阳性原始细胞百分比与髓系谱系密切相关,部分具有髓系特征的淋巴母细胞性和未分化白血病也表达GATA2。
- AML中GATA2阳性原始细胞百分比高度可变,AML原始细胞中GATA2表达升高与外周中性粒细胞减少和复杂AML细胞遗传学相关,但与MDS不同,不预测生存。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
GATA binding protein 2 (GATA2) is a conserved zinc finger transcription factor that regulates the emergence and maintenance of complex genetic programs driving development and function of hematopoietic stem and progenitor cells (HSPCs). Patients born with monoallelic GATA2 mutations develop myelodysplastic neoplasm (MDS) and acute myeloid leukemia (AML), whereas acquired GATA2 mutations are reported in 3% to 5% of sporadic AML cases. The mechanisms by which aberrant GATA2 activity promotes MDS and AML are incompletely understood. Efforts to understand GATA2 in basic biology and disease will be facilitated by the development of broadly efficacious antibodies recognizing physiologic levels of GATA2 in diverse tissue types and assays. Here, we purified a polyclonal anti-GATA2 antibody and generated multiple highly specific anti-GATA2 monoclonal antibodies, optimized them for immunohistochemistry on patient bone marrow bioosy samples, and analyzed GATA2 expression in adults with healthy bone marrow, MDS, and acute leukemia. In healthy bone marrow, GATA2 was detected in mast cells, subsets of CD34+ HSPCs, E-cadherin-positive erythroid progenitors, and megakaryocytes. In MDS, GATA2 expression correlates with bone marrow blast percentage, positively correlates with myeloid dysplasia and complex cytogenetics, and is a nonindependent negative predictor of overall survival. In acute leukemia, the percent of GATA2+ blasts closely associates with myeloid lineage, whereas a subset of lymphoblastic and undifferentiated leukemias with myeloid features also express GATA2. However, the percent of GATA2+ blasts in AML is highly variable. Elevated GATA2 expression in AML blasts correlates with peripheral neutropenia and complex AML cytogenetics but, unlike in MDS, does not predict survival.
引用
- Robbins DJ, Pavletich TS, Patil AT, et al. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia. Blood Adv. 2024. PMID: 38029365. doi:10.1182/bloodadvances.2023011554
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。